Gara Jalqabaatti › Dhibee Seli Sikiilii › Ohio
Qorannoo klinikaalii Dhibee Seli Sikiilii Ohio keessatti
Qorannoo 22 Dhibee Seli Sikiilii f Ohio keessatti hirmaatuu jiru.
Magaalota Ohio keessatti
Takkalaa qorannoo (Ingiliffa)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Univ Hosp Cleveland Med Ctr, Cleveland
- Ohio State Univ Wexner Med Ctr, Columbus
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- University Hospitals Case Medical Center, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT02824471A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0028, Cleveland
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
- Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
- University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
- fi 5 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
- University of Cincinnati College of Medicine, Cincinnati
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 14 hanga 80 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06725550Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Ohio State University, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07224360Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 50 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT04819841Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT04093986Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Nationwide Children's Hospital (NT-DMT), Columbus
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 20 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06941389A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jira
Umuriin 13 hanga 21 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT06290401Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- The Ohio State University Medical Center, Columbus
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT06919224Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Cincinnati Children's Hospital, Cincinnati
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 40 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT03587272MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
- UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
Namoota walitti qabaa jira
Umuriin 14 fi ol · Saalaa hunda · Haaromfame 29-Ama-2026 · NCT06853158A Long-term Follow-up Study in Patients Who Received BEAM-101
- University Hospitals Clevland Medical Center, Cleveland
- The Clevland Clinic Foundation, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 14 hanga 37 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07373639Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraQorannoo ilaalaa
6 Months – 6 Years · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07356050Integrative Training Program for Pediatric Sickle Cell Pain
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jira
Umuriin 12 hanga 18 · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT06691867Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 4
6 Months · Saalaa hunda · Haaromfame 16-Ful-2025 · NCT07177300HPC Offered for PRESERVE Expansion
- The Ohio State University Medical Center, Columbus
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2025 · NCT07145411Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Cleveland Clinic, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2025 · NCT06385886Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.